Nymox Pharmaceutical Corporation is engaged in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the aging population.

HASBROUCK HEIGHTS, NJ (May 6, 2013) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report on the presentation on NX-1207 drug studies at a high-level symposium and panel discussion held at the Annual Meeting of the American ...

HASBROUCK HEIGHTS, NJ (May 3, 2013) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today completion of patient enrollment in the Company's final pivotal U.S.

HASBROUCK HEIGHTS, NJ (April 30, 2013) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce further information about the upcoming Symposium on NX-1207 to be held on May 5 at 3 p.m.

HASBROUCK HEIGHTS, NJ (April 23, 2013) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that the first patient has been enrolled in the Company's Study NX02-0022.

HASBROUCK HEIGHTS, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce that the first patient has been enrolled in the Company's Study NX02-0022.

... SOFTWARE & EDP SERVICES USD 0.18 0.19 0.01 33.0 33.2 0.3 NYMOX PHARMACEUTICAL CORP Q1 DRUGS CAD -0.05 -0.03 0.02 0.8 0.8 0.1 OMNITEK ENGINEERING CORP Q1 MACHINERY USD -0.01 -0.01 0.00 675.0 349.3 -325.7 OVASCIENCE ...